Smith, I. E., Dowsett, M., Yap, Y. S., et al. (2003). Adjuvant aromatase inhibitors for early breast cancer after chemotherapy-induced menopause: The TEAM trial. Journal of Clinical Oncology, 21(21), 4009-4016.
Loibl, S., & Gianni, L. (2017). HER2-positive breast cancer. The Lancet, 389(10087), 2415-2429.
Baselga, J., et al. (2012). Pertuzumab plus Trastuzumab plus Docetaxel for Metastatic Breast Cancer. New England Journal of Medicine, 366(2), 109-119.
DeVita, V. T., & Chu, E. (2008). A history of cancer chemotherapy. Cancer Research, 68(21), 8643-8653.